There is now what is supposed to be a generic version of Ampyra. Here is the kicker the generic name is what the pharmaceutical company currently calls it now dalfampridine. They just dropped the name Ampyra and changed the color of the pill.
The pharmacist told me when I refilled the script that when a generic version comes out for a medication they stop selling the brand name.
What I don’t understand how is it considered generic when all they did was change the color of the pill and drop a name.
I get the fact trying to get another niche in the market so more insurance company will pay because it always comes down to making a profit
All drugs have a brand and generic name. After 5 years the patent on the brand runs out, and other companies can create something that acts similar, but they are not the same. The color depends on the company your pharmacy contracts with (enter lots of politics here) and this is why your pills look so different when you get admitted at the hospital (even crazier politics here).
Pharmacies make more money when you buy generic, so of course they would swap everyone out, but it usually saves you money also.
Here’s a fun read about the difference in brand/generic:
pharmacytimes.com/contribut...
No it’s the same name and company. I looked
The same company can buy the rights to the drug and make the generic. The pharma co. That makes ampyra is a small company. Amphora is one of their major $ makers. I’m not surprised they decided to buy/sell the generic when it went off patent.
Yrs ago I spoke with them about the potential cog benefits (beyond walking speed) that should be appreciated by the increased nerve conduction speed that ampyra causes. They indicated that they did not have the resources to study this. Now I see the research has been done and there are cog improvements.
Unfortunately, I do not qualify for this drug due to history of febrile seizures.